Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
| Data(s) |
2010
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_864F3EA6F2FD isbn:1097-4598[electronic], 0148-639X[linking] pmid:19918772 doi:10.1002/mus.21560 isiid:000274130700025 http://my.unil.ch/serval/document/BIB_864F3EA6F2FD.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_864F3EA6F2FD5 |
| Idioma(s) |
en |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
Muscle and Nerve, vol. 41, no. 2, pp. 286-287 |
| Palavras-Chave | #Antineoplastic Agents, Alkylating/therapeutic use; Dose-Response Relationship, Drug; Humans; Male; Melphalan/therapeutic use; Middle Aged; Myopathies, Nemaline/drug therapy; Paraproteinemias/drug therapy; Treatment Outcome |
| Tipo |
info:eu-repo/semantics/article article |
